dpp 4 inhibitors vs glp 1 agonist GLP-1 receptor versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes πππππ¬π π©π¨π¬π’ππ’π¨π§ π¨π πππ-π π’π§π‘π’ππ’ππ¨π«π¬
Description
GLP-1RA intervention was associated with a reduction in fasting insulin levels when compared to those given metformin or placebo (MD = 1.40
Epub 2024 Feb 27
Biological concern for PDAC based on preclinical studies In 2005, exenatide, the first GLP-1RA was marketed as treatment for T2D
History of organ transplant on anti-rejection medication 9
Discussion at the American Heart Association session underscored the stakes of such decisions, as it was noted that an estimated 6.6 million American adults meet the inclusion criteria for the SELECT trial
